Etiology and Clinical Manifestations of Fever in Infants Younger than 3 Months Old: A Single Institution Study, 2008-2010

3개월 미만 영아의 발열에 대한 원인 및 임상양상에 대한 단일기관 연구; 2008-2010

  • Seok, Joon Young (Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Kang, Ji Eun (Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Cho, Eun Young (Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Choi, Eun Hwa (Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Lee, Hoan Jong (Department of Pediatrics, Seoul National University Children's Hospital)
  • 석준영 (서울대학교병원 소아청소년과) ;
  • 강지은 (서울대학교병원 소아청소년과) ;
  • 조은영 (서울대학교병원 소아청소년과) ;
  • 최은화 (서울대학교병원 소아청소년과) ;
  • 이환종 (서울대학교병원 소아청소년과)
  • Received : 2012.06.29
  • Accepted : 2012.09.10
  • Published : 2012.12.25

Abstract

Purpose : The purpose of this study is to investigate clinical features and causative organisms in febrile infants younger than three months, to help identification of high risk patients for serious bacterial infection (SBI). Methods : A total of 313 febrile infants younger than three months, who had visited Seoul National University Children's Hospital from January 2008 to December 2010 were included. Clinical features, laboratory findings, causative organisms, and risk factors of SBI were analyzed by retrospective chart review. Causative bacterial or viral pathogens were identified by gram stain and cultures, rapid antigen tests, or the polymerase chain reaction from clinically reliable sources. Results : Among 313 infants, etiologic organisms were identified in 127 cases (40.6%). Among 39 cases of bacterial infections, Escherichia coli (66.7%) and Streptococcus agalactiae (12.8%) were common. Enterovirus (33.7%), respiratory syncytial virus (19.8%), and rhinovirus (18.8%) were frequently detected in 88 cases of viral infection. Patients with SBI (39 cases) showed significantly higher values of the white blood cell count ($14,473{\pm}6,824/mm^3$ vs. $11,254{\pm}5,775/mm^3$, P=0.002) and the C-reactive protein ($6.32{\pm}8.51mg/L$ vs. $1.28{\pm}2.35mg/L$, P<0.001) than those without SBI (274 cases). The clinical risk factors for SBI were the male (OR 3.7, 95% CI 1.5-8.9), the presence of neurologic symptoms (OR 4.8, 95% CI 1.4-16.8), and the absence of family members with respiratory symptoms (OR 3.6, 95% CI 1.2-11.3). Conclusion : This study identified common pathogens and risk factors for SBI in febrile infants younger than three months. These findings may be useful to guide management of febrile young infants.

목 적 : 본 연구는 발열로 내원한 3개월 미만 영아에서, 그 임상 양상과 원인균을 확인함으로써 심각한 세균감염의 고위험군을 구분하는 데 도움이 되고자 하였다. 방 법 : 2008년 1월부터 2010년 12월까지 발열을 주소로 서울대학교병원 응급실에 내원하거나 입원치료 받았던 3개월 미만 영아 313명의 의무기록을 후향적으로 분석하였다. 대상 환자들의 임상 양상, 검사 결과 및 원인 균주 등의 자료를 수집하였으며, 심각한 세균 감염의 위험 요인을 평가하였다. 그람 염색과 세균 배양, 바이러스 배양, 항원 검사, 또는 중합효소연쇄반응 검사를 시행하였을 때 임상적으로 의미 있는 검체에서 양성으로 확인된 경우 원인 균주로 채택하였다. 결 과 : 전체 313례 중 127례(40.6%)에서 미생물학적 원인이 확인되었으며, 세균 감염이 39례, 바이러스 감염이 88례를 차지하였다. 세균 감염의 원인 균주로는 Escherichia coli (66.7%)와 Streptococcus agalactiae (12.8%)가 가장 많았고, 바이러스 감염은 엔테로바이러스(33.7%), 호흡기 세포융합 바이러스(19.8%), 라이노바이러스(18.8%) 순으로 흔하게 나타났다. 심각한 세균감염군(39례)은 심각한 세균 감염이 아닌 군(274례)에 비하여 백혈구 수($14,473{\pm}6,824/mm^3$ vs. $11,254{\pm}5,775/mm^3$, P=0.002)와 C-반응단백($6.32{\pm}8.51mg/L$ vs. $1.28{\pm}2.35mg/L$, P<0.001)이 유의하게 높게 나타났다. 심각한 세균 감염의 위험 인자로는 남자(OR 3.7, 95% CI 1.5-8.9), 신경계 증상이 있는 경우(OR 4.8, 95% CI 1.4-16.8), 가족 중 호흡기 증상이 없는 경우(OR 3.6, 95% CI 1.2-11.3) 등이 있었다. 결 론 : 본 연구를 통해 발열로 내원한 3개월 미만 영아에서의 흔한 원인 균주 및 심각한 세균 감염의 위험 인자를 확인할 수 있었다. 이것은 향후 발열로 내원한 영아에 대한 치료 방침의 결정에 기초적인 자료가 될 것으로 생각된다.

Keywords

References

  1. Nelson DS, Walsh K, Fleisher GR. Spectrum and frequency of pediatric illness presenting to a general community hospital emergency department. Pediatrics 1992; 90:5-10.
  2. Baskin MN. The prevalence of serious bacterial infections by age in febrile infants during the first 3 months of life. Pediatr Ann 1993;22:462-6. https://doi.org/10.3928/0090-4481-19930801-06
  3. DeAngelis C, Joffe A, Wilson M, Willis E. Iatrogenic risks and financial costs of hospitalizing febrile infants. Am J Dis Child 1983;137:1146-9.
  4. Dagan R, Powell KR, Hall CB, Menegus MA. Identification of infants unlikely to have serious bacterial infection although hospitalized for suspected sepsis. J Pediatr 1985;107:855-60. https://doi.org/10.1016/S0022-3476(85)80175-X
  5. Dagan R, Sofer S, Phillip M, Shachak E. Ambulatory care of febrile infants younger than 2 months of age classified as being at low risk for having serious bacterial infections. J Pediatr 1988;112:355-60. https://doi.org/10.1016/S0022-3476(88)80312-3
  6. Baker MD, Bell LM, Avner JR. Outpatient management without antibiotics of fever in selected infants. N Eng J Med 1993;329:1437-41. https://doi.org/10.1056/NEJM199311113292001
  7. Lee JH, Cho HK, Kim KH, Kim CH, Kim DS, Kim KN, et al. Etiology of invasive bacterial infections in immunocompetent children in Korea (1996-2005): a retrospective multicenter study. J Korean Med Sci 2011;26:174-83. https://doi.org/10.3346/jkms.2011.26.2.174
  8. Levine DA, Platt SL, Dayan PS, Macias CG, Zorc JJ, Krief W, et al. Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections. Pediatrics 2004;113:1728-34. https://doi.org/10.1542/peds.113.6.1728
  9. Gómez B, Mintegi S, Benito J, Egireun A, Garcia D, Astobiza E. Blood culture and bacteremia predictors in infants less than three months of age with fever without source. Pediatr Infect Dis J 2010;29:43-7. https://doi.org/10.1097/INF.0b013e3181c6dd14
  10. Bressan S, Andreola B, Cattelan F, Zangardi T, Perilongo G, Da Dalt L. Predicting severe bacterial infections in well-appearing febrile neonates: laboratory markers accuracy and duration of fever. Pediatr Infect Dis J 2010; 29:227-32. https://doi.org/10.1097/INF.0b013e3181b9a086
  11. The WHO Young Infants Study Group. Bacterial etiology of serious infections in young infants in developing countries: results of a multicenter study. Pediatr Infect Dis J 1999;18:S17-22. https://doi.org/10.1097/00006454-199910001-00004
  12. Dagan R, Hall CB, Powell KR, Menegus MA. Epidemiology and laboratory diagnosis of infection with viral and bacterial pathogens in infants hospitalized for suspected sepsis. J Pediatr 1989;115:351-6. https://doi.org/10.1016/S0022-3476(89)80831-5
  13. Shin SH, Choi CW, Lee JA, Kim EK, Choi EH, Kim HS, et al. Risk factors for serious bacterial infection in febrile young infants in a community referral hospital. J Korean Med Sci 2009;24:844-8. https://doi.org/10.3346/jkms.2009.24.5.844
  14. Nah SY, Hong JY, Choi EH, Yoon BY, Lee HJ. Etiology and clinical features of acute viral lower respiratory tract infection in apparently healthy children. Korean J Pediatr 1996;39:1690-9.
  15. Kwon JH, Chung YH, Lee NY, Chung EH, Ahn KM, Lee SI. An epidemiological study of acute viral lower respiratory tract infections in hospitalized children from 2002 to 2006 in Seoul, Korea. Pediatr Allergy Respir Dis 2008;18:26-36.
  16. Byington CL, Enriquez FR, Hoff C, Tuohy R, Taggart EW, Hillyard DR, et al. Serious bacterial infections in febrile infants 1 to 90 days old with and without viral infections. Pediatrics 2004;113:1662-6. https://doi.org/10.1542/peds.113.6.1662
  17. Titus MO, Wright SW. Prevalence of serious bacterial infections in febrile infants with respiratory syncytial virus infection. Pediatrics 2003;112:282-4. https://doi.org/10.1542/peds.112.2.282
  18. Yarden-Bilavsky H, Ashkenazi-Hoffnung L, Livni G, Amir J, Bilavsky E. Month-by-month age analysis of the risk for serious bacterial infections in febrile infants with bronchiolitis. Clin Pediatr 2011;50:1052-6. https://doi.org/10.1177/0009922811412949
  19. Huppler AR, Eickhoff JC, Wald ER. Performance of low-risk criteria in the evaluation of young infants with fever: review of the literature. Pediatrics 2010;125:228-33. https://doi.org/10.1542/peds.2009-1070
  20. Baskin MN, O'Rourke EJ, Fleisher GR. Outpatient treatment of febrile infants 28 to 89 days of age with intramuscular administration of ceftriaxone. J Pediatr 1992; 120:22-7. https://doi.org/10.1016/S0022-3476(05)80591-8
  21. Baker MD, Bell LM, Avner JR. The efficacy of routine outpatient management without antibiotics of fever in selected infants. Pediatrics 1999;103:627-31. https://doi.org/10.1542/peds.103.3.627
  22. Bachur RG, Harper MB. Predictive model for serious bacterial infections among infants younger than 3 months of age. Pediatrics 2001;108:311-6. https://doi.org/10.1542/peds.108.2.311
  23. Kourtis A, Sullivan DT, Sathian U. Practice guidelines for the management of febrile infants less than 90 days of age at the ambulatory network of a large pediatric health care system in the United States: summary of new evidence. Clin Pediatr 2004;43:11-6. https://doi.org/10.1177/000992280404300102
  24. Baraff LJ. Management of infants and young children with fever without source. Pediatr Ann 2008;37:673-9. https://doi.org/10.3928/00904481-20081001-01
  25. Putto A, Ruuskanen O, Meurman O, Ekblad H, Korvenranta H, Mertsola J, et al. C reactive protein in the evaluation of febrile illness. Arch Dis Child 1986;61:24-9. https://doi.org/10.1136/adc.61.1.24
  26. Pulliam PN, Attia MW, Cronan KM. C-reactive protein in febrile children 1 to 36 months of age with clinically undetectable serious bacterial infection. Pediatrics 2001; 108:1275-9. https://doi.org/10.1542/peds.108.6.1275
  27. Baraff LJ, Bass JW, Fleisher GR, Klein JO, McCracken GH, Powell KR, et al. Practice guideline for the manage ment of infants and children 0 to 36 months of age with fever without source. Ann Emerg Med 1993;22:1198-210. https://doi.org/10.1016/S0196-0644(05)80991-6
  28. Baker MD. Evaluation and management of infants with fever. Pediatr Clin North Am 1999;46:1061-72. https://doi.org/10.1016/S0031-3955(05)70175-9
  29. Elder JS. Urinary tract infections. In: Kliegman RM, Stanton BF, St. Geme JW, Schor NF, Behrman RE, editors. Nelson textbook of pediatrics. 19th ed. Philadelphia, PA: Saunders Elsevier, 2011:1829.
  30. Libster R, Hortoneda JB, Laham FR, Casellas JM, Israele V, Polack NR, et al. Breastfeeding prevents severe disease in full term female infants with acute respiratory infection. Pediatr Infect Dis J 2009;28:131-4. https://doi.org/10.1097/INF.0b013e31818a8a82